However, these findings help delineate a scenario in which high production of hepcidin by cancer cells, and perhaps additional cell types within the tumor niche, contributes to generating a microenvironment that dampens antitumor immunity and promotes cancer progression. This evidence concerns the gene HAMP and neoplasm.